OncoDaily
LightNews LightNews
banner
oncodaily.bsky.social
OncoDaily
@oncodaily.bsky.social
3.4K followers 7.8K following 2.9K posts
Your daily dose of hope, inspiration, and information in the fight against cancer.
oncodaily.com
Posts Replies Media Videos
oncodaily.bsky.social
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Daratumumab #MM #Myeloma
November 9, 2025 at 9:10 PM
oncodaily.bsky.social
SWOG S1605: UroAmp utDNA Predicts Immunotherapy Response in Bladder Cancer

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 7, 2025 at 9:46 PM
oncodaily.bsky.social
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

oncodaily.com/community/10...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
November 7, 2025 at 9:45 PM
oncodaily.bsky.social
SRT and Immunotherapy in Asymptomatic Brain Metastatic NSCLC

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SRT #Immunotherapy #NSCLC
November 4, 2025 at 8:37 PM
oncodaily.bsky.social
Evolution Trial Evaluates Radiotherapy-Free Chemoimmunotherapy with Pembrolizumab in Locally Advanced NSCLC with High PD-L1 Expression

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Evolution #Chemoimmunotherapy #Pembrolizumab #NSCLC
November 3, 2025 at 1:49 PM
oncodaily.bsky.social
LEAP-012: Pembrolizumab Plus Lenvatinib with Transarterial Chemoembolization in Unresectable, Non-Metastatic HCC

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #LEAP-012 #HCC
November 2, 2025 at 9:41 PM
oncodaily.bsky.social
Immunotherapy Improves Survival in MSI-H Colon Cancer with Isolated Peritoneal Metastases

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ColonCancer
November 2, 2025 at 9:38 PM
oncodaily.bsky.social
LITESPARK-011: Dual HIF-2α and VEGF Pathway Blockade Demonstrates Superiority Over Cabozantinib Following PD-1/L1 Therapy in Advanced Renal Cell Carcinoma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #RCC #RenalCellCarcinoma #LITESPARK-011
October 31, 2025 at 1:36 PM
oncodaily.bsky.social
Predictive Modeling for Immunotherapy Response in Cancer: From Biomarkers to AI Integration

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Immunotherapy #IO
October 29, 2025 at 9:37 PM
oncodaily.bsky.social
Gevorg Tamamyan Recognized as Fellow of the American Society of Clinical Oncology (FASCO)

@ascocancer.bsky.social

oncodaily.com/voices/gevor...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ASCO #FASCO
October 29, 2025 at 9:36 PM
oncodaily.bsky.social
mRNA COVID-19 Vaccines Reprogram Tumor Immunity and Enhance Response to Checkpoint Inhibitors

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #COVID-19 #mRNAVaccine
October 28, 2025 at 8:49 PM
oncodaily.bsky.social
FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #FDA #Melanoma
October 26, 2025 at 9:14 PM
oncodaily.bsky.social
FDA Grants Breakthrough Therapy Designation to Zenocutuzumab-zbco for NRG1-Positive Cholangiocarcinoma

@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Cholangiocarcinoma
October 24, 2025 at 8:50 PM
oncodaily.bsky.social
Dual Immune Checkpoint Blockade Targeting TIGIT and PD-1 Improves Outcomes in Advanced Gastroesophageal Adenocarcinoma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GastroesophagealAdenocarcinoma #GIOnc
October 15, 2025 at 12:11 AM
oncodaily.bsky.social
PIVOTAL Trial Shows Daromun Improves Recurrence-Free Survival in Stage III Melanoma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Melanoma #PIVOTAL
October 9, 2025 at 7:08 AM
oncodaily.bsky.social
Biomarkers and Dual Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Survival

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #NSCLC #LungCancer
October 5, 2025 at 6:54 PM
oncodaily.bsky.social
FDA Approves Lurbinectedin Plus Atezolizumab for Maintenance in Extensive-Stage Small Cell Lung Cancer

oncodaily.com/fda-approval...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
October 3, 2025 at 8:02 PM
oncodaily.bsky.social
Overcoming Antigen Escape With Fas FasL Bystander Killing in CAR-T Therapy

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
October 1, 2025 at 8:38 PM
oncodaily.bsky.social
In Vivo Genome-Wide CRISPR Screens in Human T Cells to Enhance T Cell Therapy for Solid Tumors

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #SolidTumors #CRISPR
September 30, 2025 at 10:01 PM
oncodaily.bsky.social
OncoDaily LA is here!

We’re proud to launch OncoDaily LA, a new regional hub of OncoDaily, where oncology meets culture, community, and creative advocacy.

oncodaily.com/voices/oncod...

#OncoDailyLA #CancerMedia #OncologyCalifornia #YouthOutreach #PalliativeCare #LosAngeles #OncoDaily #OncoDailyTV
September 24, 2025 at 12:28 PM
oncodaily.bsky.social
Burnout Affects Over 50% of Palliative Care Clinicians and the Problem is not the Patients - Eduardo Bruera

@brueraeduardo.bsky.social

oncodaily.com/voices/372493

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #PalliativeCare
September 18, 2025 at 12:37 PM
oncodaily.bsky.social
Tumor-Infiltrating Lymphocytes (TILs): How Our Immune System Enters the Fight Against Cancer

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #TILs
September 17, 2025 at 2:50 PM
oncodaily.bsky.social
A Systematic Review and Meta-Analysis of Cancer in Inborn Errors of Immunity

@springernature.com

oncodaily.com/new-paper-al...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
September 16, 2025 at 1:38 PM
oncodaily.bsky.social
Perioperative Nivolumab ± Ipilimumab in Resectable Diffuse Pleural Mesothelioma

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Nivolumab #Ipilimumab #IO #DiffusePleuralMesothelioma #Mesothelioma
September 15, 2025 at 12:54 PM
oncodaily.bsky.social
Join Us for Global Voices in Renal Oncology Virtual Congress 2025

@yukselurun.bsky.social

oncodaily.com/pulse/global...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
September 9, 2025 at 12:22 PM